| Trial ID: | L2576 |
| Source ID: | NCT00446810
|
| Associated Drug: |
Benfotiamine
|
| Title: |
Chronic Treatment With Benfotiamine Restores Endothelial Function in People With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Benfotiamine|DRUG: Placebo
|
| Outcome Measures: |
Primary: Endothelial function (flow mediated dilatation - ultrasound- and reactive hyperemia- laser doppler-), September 2007- December 2008 | Secondary: Parameters of autonomic neuropathy, September 2007- December 2008
|
| Sponsor/Collaborators: |
Sponsor: Ruhr University of Bochum
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
|
| Start Date: |
2007-09
|
| Completion Date: |
2008-12
|
| Results First Posted: |
|
| Last Update Posted: |
2007-09-27
|
| Locations: |
Herz- und Diabeteszentrum NRW, Georgstr. 11, Bad Oeynhausen, North Rhine-Westphalia, 32545, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00446810
|
